4757
-
OncoTargets and Therapy
Dr Pérez-López (Logout)
My Dovepress
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Real benefits for authors, including fast-track processing of papers.
OncoTargets and Therapy
(165,525) Views
Editor in Chief Professor Hans-Joachim Schmoll
1178-6930
Bendamustine in the treatment of non-Hodgkin’s lymphomasFredrick Hagemeister, George Manoukian
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Khaldoun Almhanna, Philip A Philip
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Francesco Perri, Francesco Longo, Franco Ionna, et al
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Charu Aggarwal, Hossein Borghaei
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
Michael J Burdick, Roger M Macklis
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
Kelly M Reilly, David F Kisor
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
Luca Toschi, Federico Cappuzzo
Expanded use of rituximab in the management of non-Hodgkin lymphoma
Dennis A Eichenauer, Andreas Engert, Holger Schulz
Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
Martina Lehnert, Heinz Ludwig, Niklas Zojer
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
Francesco Di Costanzo, Silvia Gasperoni, Virginia Rotella, Federica Di Costanzo
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Kerry J Williams, A Craig Lockhart
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
A Milano, F Perri, F Caponigro
Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
John T Vetto
Multiple roles and therapeutic implications of Akt signaling in cancer
Emiliano Calvo, Victoria Bolós, Enrique Grande
Targeted therapy in the treatment of malignant gliomas
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas
Role of trabectedin in the treatment of soft tissue sarcoma
Alexandre Christinat, Serge Leyvraz
The evolving role of zoledronic acid in early breast cancer
Michael Gnant
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
Charles Chuah, Junia V Melo
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
Giuseppe Tonini, Alice Calvieri, Bruno Vincenzi, Daniele Santini
Targeted treatment of chronic myeloid leukemia: role of imatinib
Ila Tamascar, Jeyanthi Ramanarayanan
Targeting cancers in the gastrointestinal tract: role of capecitabine
Muhammad Wasif Saif
Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma
Anita Schwandt1, Laura S Wood1, Brian Rini1,2, Robert Dreicer1,2
Role of bendamustine in the treatment of chronic lymphocytic leukemia
Saad Jamshed, Bruce D Cheson
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
Per Pfeiffer, Camilla Qvortrup, Jon K Bjerregaard
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Ajithkumar Puthillath, Anush Patel, Marwan G Fakih
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
